KR900011486A - 하이드로겔에 의해 작동되는 분배장치 - Google Patents
하이드로겔에 의해 작동되는 분배장치 Download PDFInfo
- Publication number
- KR900011486A KR900011486A KR1019900000280A KR900000280A KR900011486A KR 900011486 A KR900011486 A KR 900011486A KR 1019900000280 A KR1019900000280 A KR 1019900000280A KR 900000280 A KR900000280 A KR 900000280A KR 900011486 A KR900011486 A KR 900011486A
- Authority
- KR
- South Korea
- Prior art keywords
- layer
- dispensing device
- hydrogel
- mixture
- osmosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Colloid Chemistry (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Materials For Medical Uses (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 정제 형태인, 본 발명장치(1)의 한 태양의 투시도이다, 제2도는 제1도에 나타내 장치(1)를 선2-2에 따라 절단한 횡단면도이다, 제3도는 장치(1)를 둘러싸고 있는 코팅(3)안에 2개의 층(6과7)을 포함하는 제1도에 나타낸 장치(1)를 선2-2에 따라 절단한 장치(1)의 또 다른 태챵의 횡단면도이다.
Claims (37)
- (a)하나 이상의 유익한 약물과 하이드로겔을 포함하는 혼합물과 (b) 상기 혼합물을 둘러싸고 있고, 다수의 기공을 함유한 코팅을 포함하는 분배장치.
- 제1항에 있어서, 상기 유익한 약물이 약제이고, 상기 하이드로겔이 폴리에틸렌 옥사이드이고, 상기 코팅이 셀룰로즈 아세테이트를 포함하는 분배장치.
- 제1항에 있어서, 상기 혼합물이 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- 제1항 내지 제3항중 어느 한 항에 있어서, 상기 코팅이 적어도 하나의 구멍(hole)을 추가로 함유하는 분배장치.
- (a)하나 이상의 유익한 약물과 하이드로겔을 포함하는 혼합물과, (b)상기 혼합물을 둘러싸고 있고, 중합체와 하나 이상의 가공형성제(porosigens)를 함유한 코팅을 포함하는 분배장치.
- 제5항에 있어서, 상기 유익한 약물이 약제이고, 상기 하이드로겔이 폴리에틸렌 옥사이드이고, 상기 코팅 중합체가 셀룰로즈 아세테이트인 분배장치.
- 제5항 또는 제6항에 있어서, 상기 기공형성제가 하나 이상의 수용성 중합체인 분배장치.
- 제7항에 있어서, 상기 수용성 중합체가 하이드록시프로필 셀룰로즈, 폴리에틸렌 글리콜 및 폴리에틸렌 옥사이드로 구성된 그룹중에서 선택되는 분배장치.
- 제5항 또는 제6항에 있어서, 상기 기공형성제가 하나 이상의 수용성 중합체와 하나 이상의 무기염인 분배장치.
- 제5항 또는 제6항에 있어서, 상기 기공형성제가 하나 이상의 수용성 중합체와 하나 이상의 수용성 미립유기 화합물 및 그의 염인 분배장치.
- 제10항에 있어서, 상기 수용성 중합체가 폴리에틸렌 글리콜-600이고 상기 수용성 미립 유기화합물이 슈크로즈인 분배장치.
- 제5항 또는 제6항에 있어서, 상기 기공형성제가 하나 이상의 무기염 또는 하나이상의 수용성 미립 유기 화합물 및 그의 염인 분배장치.
- 제5항에 있어서, 상기 혼합물이 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- 제5항에 있어서, 상기 코팅이 적어도 하나의 구멍을 추가로 함유하는 분배장치.
- (a)하나 이상의 유익한 약물과 하이드로겔의 혼합물을 포함하는 제1층, (b)상기 제1층에 인접해 있으며 제1층과 접촉하는 지대를 포함하는 하이드로겔을 함유한 제2층 및 (c)제1층과 제2층이 접촉하고 있는 상기 지대를 제외한 제1층과 제2층을 둘러싸고 있고, 상기 제1층에 인접한 구멍을 적어도 한개 함유한 코팅을 포함한 분배장치.
- 제15항에 있어서, 상기 제1층 또는 제2층이 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- 제15항에 있어서, 상기 제1층과 제2층이 각각 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- 제15항에 있어서, 상기 코팅이 다수의 기공을 추가로 함유하는 분배장치.
- 제15항 내지 제18항중 어느 한 항에 있어서, 적어도 1개의 구멍을 함유하는 상기 코팅이 중합체와 하나 이상의 기공형성체를 포함하는 분배장치.
- (a)하나 이상의 유익한 약물과 하이드로겔의 혼합물을 포함하는 제1층, (b)상기 제1층에 인접해 있고 제1층과 접촉하는 지대를 포함하는, 하이드로겔을 함유한 제2층 및 (c)제1층과 제2층이 접촉하고 있는 상기 지대를 제외한 제1층과 제2층을 둘러싸고 있고, 중합체와 하나 이상의 가공형성제를 함유한 코팅을 포함하는 분배장치.
- 제20항에 있어서, 상기 제1층 또는 제2층이 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- 제20항에 있어서, 상기 제1층 및 제2층이 각각 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- (a)하이드로겔을 포함하는 가장 안쪽의 층, (b)상기 가장 안쪽의 층에 인접하여 그 층을 둘러싸고 있고, 하나 이상의 유익한 약물과 하이그로겔의 혼합물을 포함하는 가장 바깥쪽의 층 및 (c) 상기 가장 바깥쪽의 층을 둘러싸고 있고, 다수의 기공을 함유한 코팅을 포함하는 분배장치.
- 제23항에 있어서, 상기 가장안쪽의 층 또는 가장 바깥쪽의 층이 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- 제23항에 있어서, 상기 가장 안쪽의 층 및 가장 바깥쪽의 층이 각각 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- (a)하이드로겔을 포함하는 가장 안쪽의 층, (b)상기 가장 안쪽의 층에 인접하여 그 층을 둘러싸고 있고, 하나 이상의 유익한 약물과 하이드로겔의 혼합물을 포함하는 가장 바깥쪽의 층 및 (c) 상기 가장 바깥쪽의 층을 둘러싸고 있고, 중합체와 하나 이상의 기공형성제를 함유한 코팅을 포함하는 분배장치.
- 제26항에 있어서, 상기 가정 안쪽의 층 또는 가장 바깥쪽의 층이 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- 제26항에 있어서, 상기 가정 안쪽의 층 및 가장 바깥쪽의 층이 각각 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- (a) 하나 이상의 유익한 약물과 하이드로겔을 포함하는 혼합물 및 (b)상기 혼합물을 둘러싸고 있고, 하나 이상의 구멍을 함유한 코팅을 포함하는 분배장치.
- 제29항에 있어서, 상기 혼합물이 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- (a)하나 이상의 유익한 약물과 하이드로겔의 혼합물을 포함하는 제1층, (b)상기 제1층에 인접해 있고 제1층과 접촉하는 있는 지대를 포함하는 하이드로겔을 함유한 제2층 및 (c)제1층과 제2층이 접촉하고 있는 상기 지대를 제외한 제1층과 제2층을 둘러싸고 있고, 다수의 기공을 함유한 코팅을 포함하는 분배장치.
- 제31항에 있어서, 상기 제1층 또는 제2층이 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- 제31항에 있어서, 상기 제1층과 2층이 각각 삼투에 효과적인 용질을 추가로 포함하는 분배장치.
- 제1항 내지 제33항중 어느 한 항에 청구된 장치를 유용한 환경에 놓음을 포함하는 하나 이상의 유익한 약물을 유용한 환경에 조절하면서 전달하는 방법.
- 장치내의 유익한 약물이 약제인 제1항, 5항, 15항, 20항, 23항, 26항, 29항, 또는 31항중 어느 한 항에 청구된 장치를 동물에 투여함을 포함하는 동물에게 약제를 조절하면서 전달하는 방법.
- 수용성 벽과 하나 이상의 제26항의 장치를 포함하는 캅셀.
- 장치내의 유익한 약물이 약제인 제36항에 청구된 장치를 동물에게 투여함을 포함하는, 동물에게 약제를 조절하면서 전달하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29646489A | 1989-01-12 | 1989-01-12 | |
US296,464 | 1989-01-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900011486A true KR900011486A (ko) | 1990-08-01 |
KR920008702B1 KR920008702B1 (ko) | 1992-10-08 |
Family
ID=23142114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900000280A KR920008702B1 (ko) | 1989-01-12 | 1990-01-11 | 하이드로겔에 의해 작동되는 분배 장치 |
Country Status (19)
Country | Link |
---|---|
US (2) | US5516527A (ko) |
EP (1) | EP0378404B1 (ko) |
JP (1) | JPH07119171B2 (ko) |
KR (1) | KR920008702B1 (ko) |
AT (1) | ATE110578T1 (ko) |
AU (1) | AU615129B2 (ko) |
CA (1) | CA2007463C (ko) |
DE (1) | DE69011878T2 (ko) |
DK (1) | DK0378404T3 (ko) |
ES (1) | ES2058775T3 (ko) |
FI (1) | FI900153A (ko) |
HU (1) | HUT54038A (ko) |
IE (1) | IE64201B1 (ko) |
IL (1) | IL92966A (ko) |
MY (1) | MY105761A (ko) |
NO (1) | NO900151L (ko) |
NZ (1) | NZ232078A (ko) |
PT (1) | PT92838B (ko) |
ZA (1) | ZA90197B (ko) |
Families Citing this family (164)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366738A (en) * | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
US5024843A (en) * | 1989-09-05 | 1991-06-18 | Alza Corporation | Oral hypoglycemic glipizide granulation |
US6764697B1 (en) | 1991-06-27 | 2004-07-20 | Alza Corporation | System for delaying drug delivery up to seven hours |
US5160744A (en) * | 1991-06-27 | 1992-11-03 | Alza Corporation | Verapmil therapy |
EP0607321A1 (en) * | 1991-10-10 | 1994-07-27 | Alza Corporation | Osmotic drug delivery devices with hydrophobic wall materials |
US5543154A (en) * | 1991-12-27 | 1996-08-06 | Merck & Co., Inc. | Controlled release nifedipine delivery device |
PL171110B1 (pl) * | 1991-12-27 | 1997-03-28 | Merck & Co Inc | Sposób wytwarzania tabletki do kontrolowanego wytwarzania i uwalniania in situ dyspersji zawierajacej lek PL PL PL |
US5330762A (en) * | 1992-02-27 | 1994-07-19 | Alza Corporation | Tandospiaine antidepressive therapy |
ZA935569B (en) * | 1992-07-31 | 1994-04-12 | Daratech Pty Ltd | Controlled release implants |
AU682827B2 (en) * | 1992-09-18 | 1997-10-23 | Astellas Pharma Inc. | Sustained-release hydrogel preparation |
JPH06256166A (ja) * | 1993-01-06 | 1994-09-13 | ▲寛▼治 ▲高▼田 | 薬物放出制御製剤 |
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
WO1995030422A1 (en) * | 1994-05-06 | 1995-11-16 | Pfizer Inc. | Controlled-release dosage forms of azithromycin |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
US5654005A (en) * | 1995-06-07 | 1997-08-05 | Andrx Pharmaceuticals, Inc. | Controlled release formulation having a preformed passageway |
GB9523752D0 (en) * | 1995-11-21 | 1996-01-24 | Pfizer Ltd | Pharmaceutical formulations |
US6096339A (en) * | 1997-04-04 | 2000-08-01 | Alza Corporation | Dosage form, process of making and using same |
GB9611328D0 (en) * | 1996-05-31 | 1996-08-07 | Zeneca Ltd | Pharmaceutical compositions |
CA2269707C (en) * | 1996-10-25 | 2005-08-16 | Edward M. Rudnic | Soluble form osmotic dose delivery system |
EP1027888B1 (en) * | 1999-02-10 | 2009-06-10 | Pfizer Products Inc. | Osmotic system for delivery of solid amorphous dispersions of drugs |
US6706283B1 (en) | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
US6228392B1 (en) * | 1999-04-29 | 2001-05-08 | Gene Tools, Llc | Osmotic delivery composition, solution, and method |
US6251432B1 (en) * | 1999-07-01 | 2001-06-26 | Abbott Laboratories | Sustained release dosage form unit having latex coating and method of making the same |
WO2001047498A2 (en) | 1999-12-23 | 2001-07-05 | Pfizer Products Inc. | Hydrogel-driven layered drug dosage form comprising sertraline |
EP1242055B1 (en) * | 1999-12-23 | 2008-04-23 | Pfizer Products Inc. | Hydrogel-driven drug dosage form |
EP1738749A1 (en) | 1999-12-23 | 2007-01-03 | Pfizer Products Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
US6352721B1 (en) | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
US6753011B2 (en) | 2000-01-14 | 2004-06-22 | Osmotica Corp | Combined diffusion/osmotic pumping drug delivery system |
US6669954B2 (en) | 2000-01-25 | 2003-12-30 | John R. Crison | Controlled release of drugs |
US6296993B1 (en) | 2000-06-13 | 2001-10-02 | Eastman Kodak Company | Method of providing digitized photographic image |
US6361225B1 (en) | 2000-06-13 | 2002-03-26 | Eastman Kodak Company | Apparatus for providing a photochemical reaction |
US6309810B1 (en) | 2000-06-13 | 2001-10-30 | Eastman Kodak Company | Photochemical delivery article and method of use |
US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
US6770721B1 (en) * | 2000-11-02 | 2004-08-03 | Surface Logix, Inc. | Polymer gel contact masks and methods and molds for making same |
JPWO2002064114A1 (ja) * | 2001-02-15 | 2004-06-10 | 株式会社三和化学研究所 | 新規眼科用組成物 |
EP1372614A4 (en) * | 2001-03-16 | 2007-10-31 | Andrx Pharmaceuticals Llc | SULPHONYL UREA FORMULATION WITH CONTROLLED RELEASE |
US20030008007A1 (en) * | 2001-04-23 | 2003-01-09 | Jose Gutierrez-Rocca | Release pharmaceutical construct for gastric retention |
CA2461354C (en) * | 2001-09-28 | 2010-04-27 | Mcneil-Ppc, Inc. | Fondant-based pharmaceutical composition |
JP2005528330A (ja) * | 2001-11-30 | 2005-09-22 | ファイザー・プロダクツ・インク | 5,7,14−トリアザテトラシクロ[10.3.1.02,11.04,9]−ヘキサデカ−2(11)3,5,7,9−ペンタエンの医薬組成物 |
CA2473991C (en) | 2002-02-01 | 2009-09-15 | Pfizer Products Inc. | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
US7125563B2 (en) * | 2002-04-12 | 2006-10-24 | Dava Pharmaceuticals, Inc. | Sustained release pharmaceutical preparations and methods for producing the same |
CA2484874A1 (en) * | 2002-05-06 | 2003-11-13 | Ranbaxy Laboratories Limited | Monocompartment osmotic controlled drug delivery system |
AU2003256844A1 (en) * | 2002-07-29 | 2004-02-16 | Alza Corporation | Methods and dosage forms for controlled delivery of paliperidone |
US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
UY28326A1 (es) * | 2003-05-22 | 2004-06-30 | Osmotica Argentina S A | Dispositivo de ruptura de liberacion controlada con un pasaje preformado |
US8029822B2 (en) | 2003-05-22 | 2011-10-04 | Osmotica Kereskedelmi és Seolgáltató KFT | Rupturing controlled release device having a preformed passageway |
CA2530136C (en) | 2003-06-26 | 2012-10-16 | Control Delivery Systems, Inc. | In-situ gelling drug delivery system |
WO2005000268A2 (en) | 2003-06-26 | 2005-01-06 | Control Delivery Systems, Inc. | Bioerodible sustained release drug delivery systems |
US20050142203A1 (en) * | 2003-12-30 | 2005-06-30 | Grant Heinicke | Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same |
NZ552793A (en) * | 2004-08-02 | 2011-01-28 | Samyang Corp | Biodegradable multi-block polymeric composition capable of sol-gel transition |
WO2006054152A1 (en) * | 2004-11-22 | 2006-05-26 | Ranbaxy Laboratories Limited | Monocompartment osmotic-controlled delivery system of doxazosin |
JP2007070344A (ja) * | 2005-08-11 | 2007-03-22 | Tsukioka:Kk | 内服薬 |
CA2949643C (en) * | 2005-09-27 | 2018-05-15 | Tissuetech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
US8187639B2 (en) | 2005-09-27 | 2012-05-29 | Tissue Tech, Inc. | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment |
NZ543314A (en) * | 2005-10-28 | 2007-08-31 | Interag | A delivery system where the driving substance contains the active component |
AP3071A (en) | 2005-11-28 | 2014-12-31 | Marinus Pharmaceuticals | Ganaxolone formulations and methods for the makingand use thereof |
ATE510538T1 (de) | 2006-08-11 | 2011-06-15 | Univ Johns Hopkins | Zusammensetzungen und verfahren für nervenschutz |
US7838716B2 (en) * | 2006-08-11 | 2010-11-23 | Feg Holdings, Llc | High speed swelling, pressure exerting hemostatic device |
NZ601278A (en) | 2006-09-22 | 2013-09-27 | Pharmacyclics Inc | Inhibitors of Bruton's tyrosine kinase |
US8812637B2 (en) * | 2006-11-28 | 2014-08-19 | International Business Machines Corporation | Aggregation of multiple media streams to a user |
US20080127272A1 (en) * | 2006-11-28 | 2008-05-29 | Brian John Cragun | Aggregation of Multiple Media Streams to a User |
US8637080B2 (en) | 2007-06-28 | 2014-01-28 | Osmotica Kereskedelmi és Szolgáltató, KFT | Rupturing controlled release device comprising a subcoat |
CN101854933A (zh) | 2007-09-10 | 2010-10-06 | 钙医学公司 | 调节细胞内钙的化合物 |
WO2009122431A2 (en) * | 2008-02-15 | 2009-10-08 | Sun Pharma Advanced Research Company Ltd., | Oral controlled release tablet |
WO2010027875A2 (en) | 2008-08-27 | 2010-03-11 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
DK2421901T3 (en) | 2009-04-24 | 2016-01-11 | Tissue Tech Inc | Compositions comprising HC-HA complex, and methods of use thereof |
SG176785A1 (en) | 2009-06-16 | 2012-01-30 | Pfizer | Dosage forms of apixaban |
US20130029970A1 (en) | 2009-07-10 | 2013-01-31 | Ironwood Pharmaceuticals, Inc | CB Receptor Agonists |
US7718662B1 (en) | 2009-10-12 | 2010-05-18 | Pharmacyclics, Inc. | Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase |
JP2013509963A (ja) | 2009-11-09 | 2013-03-21 | スポットライト テクノロジー パートナーズ エルエルシー | 断片化ヒドロゲル |
NZ599524A (en) | 2009-11-09 | 2014-04-30 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
UY33110A (es) | 2009-12-23 | 2011-07-29 | Ironwood Pharmaceuticals Inc | Moduladores de CRTH2 |
US20130178453A1 (en) | 2010-02-09 | 2013-07-11 | Ironwood Pharmaceuticals, Inc. | Cannabinoid Agonists |
US20130196960A1 (en) | 2010-02-09 | 2013-08-01 | Ironwood Pharmaceuticals, Inc. | Cannabinoid Receptor Agonists |
WO2011115804A1 (en) | 2010-03-17 | 2011-09-22 | Ironwood Pharmaceuticals, Inc. | Sgc stimulators |
AU2011230778A1 (en) | 2010-03-23 | 2012-08-02 | Aska Pharmaceutical Co., Ltd. | Solid preparation |
EP2558866B1 (en) | 2010-04-15 | 2016-08-17 | Tracon Pharmaceuticals, Inc. | Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors |
JP6112486B2 (ja) | 2010-04-27 | 2017-04-12 | カルシメディカ,インク. | 細胞内カルシウムを調節する化合物 |
WO2011139765A2 (en) | 2010-04-27 | 2011-11-10 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
AU2011261185A1 (en) | 2010-06-03 | 2013-01-10 | Pharmacyclics, Inc. | The use of inhibitors of Bruton's tyrosine kinase (Btk) |
BR112012033341B1 (pt) | 2010-06-30 | 2022-08-23 | Cyclerion Therapeutics, Inc | Estimulantes de sgc |
WO2012009137A1 (en) | 2010-07-12 | 2012-01-19 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
US20130259830A1 (en) | 2010-07-12 | 2013-10-03 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
CN103180316A (zh) | 2010-08-27 | 2013-06-26 | 钙医学公司 | 调节细胞内钙的化合物 |
JP5878546B2 (ja) | 2010-11-09 | 2016-03-08 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | sGC刺激剤 |
WO2012149486A1 (en) | 2011-04-28 | 2012-11-01 | Tissuetech, Inc. | Methods of modulating bone remodeling |
US9682044B2 (en) | 2011-06-10 | 2017-06-20 | Tissuetech, Inc. | Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof |
US9492423B2 (en) | 2011-09-13 | 2016-11-15 | Pharmacyclics Llc | Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof |
US9139564B2 (en) | 2011-12-27 | 2015-09-22 | Ironwood Pharmaceuticals, Inc. | 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators |
US8377946B1 (en) | 2011-12-30 | 2013-02-19 | Pharmacyclics, Inc. | Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
HUE049690T2 (hu) | 2012-01-06 | 2020-10-28 | Lundbeck La Jolla Research Center Inc | Karbamátvegyületek és eljárások azok elõállítására és alkalmazására |
US9046085B2 (en) * | 2012-03-14 | 2015-06-02 | Eden Medical, Inc. | Miniature pumps |
WO2013155422A1 (en) | 2012-04-12 | 2013-10-17 | Ironwood Pharmaceuticals, Inc. | Methods of treating alopecia and acne |
US9540382B2 (en) | 2012-06-04 | 2017-01-10 | Pharmacyclics Llc | Crystalline forms of a Bruton's tyrosine kinase inhibitor |
JP2015528001A (ja) | 2012-07-11 | 2015-09-24 | ティッシュテック,インク. | Hc−ha/ptx3複合体を含む組成物およびその使用方法 |
US9309235B2 (en) | 2012-09-18 | 2016-04-12 | Ironwood Pharmaceuticals, Inc. | SGC stimulators |
CA2885645A1 (en) | 2012-09-19 | 2014-03-27 | Ironwood Pharmaceuticals, Inc. | Sgc stimulators |
US9416141B2 (en) | 2012-09-28 | 2016-08-16 | University Of Washington Through Its Center For Commercialization | Compounds and methods for preventing, treating and/or protecting against sensory hair cell death |
US9512116B2 (en) | 2012-10-12 | 2016-12-06 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
US9555007B2 (en) | 2013-03-14 | 2017-01-31 | Massachusetts Institute Of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
US10172791B2 (en) * | 2013-03-14 | 2019-01-08 | Massachusetts Institute Of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
PT2970243T (pt) | 2013-03-15 | 2020-03-05 | Cyclerion Therapeutics Inc | Estimuladores de sgc |
WO2015054283A1 (en) | 2013-10-08 | 2015-04-16 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
GB201319791D0 (en) * | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
KR20160093675A (ko) | 2013-12-05 | 2016-08-08 | 파마싸이클릭스 엘엘씨 | 브루톤 티로신 키나제의 억제제 |
US20160311826A1 (en) | 2013-12-11 | 2016-10-27 | Ironwood Pharmaceuticals, Inc. | Sgc stimulators |
CN104971414A (zh) * | 2014-04-01 | 2015-10-14 | 黄震山 | 药物缓释器 |
EP3134418A4 (en) | 2014-04-23 | 2018-01-03 | The Research Foundation for The State University of New York | A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith |
TW201603818A (zh) | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
US9839644B2 (en) | 2014-09-09 | 2017-12-12 | ARKAY Therapeutics, LLC | Formulations and methods for treatment of metabolic syndrome |
US20170298055A1 (en) | 2014-09-17 | 2017-10-19 | Ironwood Pharmaceuticals, Inc. | sGC STIMULATORS |
JP6624616B2 (ja) | 2014-09-17 | 2019-12-25 | サイクレリオン・セラピューティクス,インコーポレーテッド | sGC刺激剤 |
AU2015317823A1 (en) | 2014-09-17 | 2017-03-23 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
US9359316B1 (en) | 2014-11-25 | 2016-06-07 | Concentric Analgesics, Inc. | Prodrugs of phenolic TRPV1 agonists |
KR102557184B1 (ko) | 2015-02-06 | 2023-07-18 | 유니버시티 오브 워싱톤 | 감각 유모 세포 사멸을 예방 또는 치료하기 위한 화합물 및 방법 |
US10227333B2 (en) | 2015-02-11 | 2019-03-12 | Curtana Pharmaceuticals, Inc. | Inhibition of OLIG2 activity |
WO2016138025A2 (en) | 2015-02-23 | 2016-09-01 | Tissuetech, Inc. | Apparatuses and methods for treating ophthalmic diseases and disorders |
EA039121B1 (ru) | 2015-02-27 | 2021-12-07 | Куртана Фармасьютикалс, Инк. | ИНГИБИРОВАНИЕ АКТИВНОСТИ Olig2 |
RS65234B1 (sr) | 2015-03-03 | 2024-03-29 | Pharmacyclics Llc | Farmaceutske formulacije inhibitora brutonove tirozin kinaze |
MA41827A (fr) | 2015-03-27 | 2018-01-30 | Pharmacyclics Llc | Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton |
MA41828A (fr) | 2015-03-27 | 2018-01-30 | Pharmacyclics Llc | Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton |
CA2984480A1 (en) | 2015-05-11 | 2016-11-17 | Abide Therapeutics, Inc. | Methods of treating inflammation or neuropathic pain |
EP3297645A4 (en) | 2015-05-20 | 2018-12-12 | Tissuetech, Inc. | Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
BR112018003836A2 (pt) | 2015-08-31 | 2018-12-04 | Pharmacyclics Llc | combinações de inibidor de btk para tratar mieloma múltiplo |
FI3827838T3 (fi) | 2015-12-16 | 2023-06-19 | Walter & Eliza Hall Inst Medical Res | Sytokiini-indusoidun sh2-proteiinin estäminen nk-soluissa |
JP7109365B2 (ja) | 2016-01-19 | 2022-07-29 | ヤンセン ファーマシューティカ エヌ.ベー. | Btk阻害剤を含む製剤/組成物 |
US20190290650A1 (en) | 2016-01-19 | 2019-09-26 | Janssen Pharmaceutic Nv | Formulations/compositions comprising a btk inhibitor |
TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
WO2017147146A1 (en) | 2016-02-23 | 2017-08-31 | Concentric Analgesics, Inc. | Prodrugs of phenolic trpv1 agonists |
EP3442538A4 (en) | 2016-04-04 | 2019-11-20 | Sinopia Biosciences, Inc. | TREATMENT OF EXTRAPYRAMIDAL SYNDROME WITH TRAPIDILE |
US10821105B2 (en) | 2016-05-25 | 2020-11-03 | Concentric Analgesics, Inc. | Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia |
WO2017205766A1 (en) | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
WO2017205762A1 (en) | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
WO2017205769A1 (en) | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
JP2019524747A (ja) | 2016-07-18 | 2019-09-05 | アースローシ セラピューティクス,インク. | 痛風または高尿酸血症に関連する症状を処置または予防するための化合物、組成物、および方法 |
CA3035123A1 (en) | 2016-08-26 | 2018-03-01 | Curtana Pharmaceuticals, Inc. | Inhibition of olig2 activity |
RS62256B1 (sr) | 2016-09-02 | 2021-09-30 | Cyclerion Therapeutics Inc | Fuzionisani biciklični sgc stimulatori |
SG10202104876SA (en) | 2016-11-08 | 2021-06-29 | Cyclerion Therapeutics Inc | Sgc stimulators |
EA201991147A1 (ru) | 2016-11-08 | 2019-11-29 | ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ ЦЕНТРАЛЬНОЙ НЕРВНОЙ СИСТЕМЫ С ПОМОЩЬЮ СТИМУЛЯТОРОВ sGC | |
CA3043609A1 (en) | 2016-11-16 | 2018-05-24 | Abide Therapeutics, Inc. | Pharmaceutical formulations |
EA201991086A1 (ru) | 2016-11-16 | 2019-11-29 | Кристаллические формы ингибитора magl | |
WO2019046731A1 (en) | 2017-09-01 | 2019-03-07 | University Of Washington | CRYSTALLINE FORMS OF COMPOUNDS FOR PREVENTING OR TREATING DEATH OF SENSORY CILIC CELLS |
US11685722B2 (en) | 2018-02-28 | 2023-06-27 | Curtana Pharmaceuticals, Inc. | Inhibition of Olig2 activity |
CA3107433A1 (en) | 2018-07-27 | 2020-01-30 | Concentric Analgesics, Inc. | Pegylated prodrugs of phenolic trpv1 agonists |
BR112021011578A2 (pt) | 2018-12-31 | 2021-08-31 | Biomea Fusion, Llc | Inibidores irreversíveis de interação menina-mll |
US20220265630A1 (en) | 2019-03-15 | 2022-08-25 | Unicycive Therapeutics Inc. | Nicorandil derivatives |
EP4139288A1 (en) | 2020-04-21 | 2023-03-01 | H. Lundbeck A/S | Synthesis of a monoacylglycerol lipase inhibitor |
EP4263542A1 (en) | 2020-12-16 | 2023-10-25 | Biomea Fusion, Inc. | Fused pyrimidine compounds as inhibitors of menin-mll interaction |
WO2022150525A1 (en) | 2021-01-06 | 2022-07-14 | Awakn Life Sciences | Mdma in the treatment of alcohol use disorder |
CA3218884A1 (en) | 2021-05-11 | 2022-11-17 | David Nutt | Therapeutic aminoindane compounds and compositions |
AU2022283967A1 (en) | 2021-06-03 | 2024-01-18 | Arcadia Medicine, Inc. | Enantiomeric entactogen compositions and methods of their use |
US20230120115A1 (en) | 2021-08-11 | 2023-04-20 | Biomea Fusion, Inc. | Covalent inhibitors of menin-mll interaction for diabetes mellitus |
TW202313004A (zh) | 2021-08-20 | 2023-04-01 | 美商拜歐米富士恩股份有限公司 | Menin-mll相互作用之不可逆抑制劑的結晶形式 |
WO2023027966A1 (en) | 2021-08-24 | 2023-03-02 | Biomea Fusion, Inc. | Pyrazine compounds as irreversible inhibitors of flt3 |
WO2023039240A1 (en) | 2021-09-13 | 2023-03-16 | Biomea Fusion, Inc. | IRREVERSIBLE INHIBITORS OF KRas |
WO2023086341A1 (en) | 2021-11-09 | 2023-05-19 | Biomea Fusion, Inc. | Inhibitors of kras |
WO2023129667A1 (en) | 2021-12-30 | 2023-07-06 | Biomea Fusion, Inc. | Pyrazine compounds as inhibitors of flt3 |
WO2023139163A1 (en) | 2022-01-19 | 2023-07-27 | Awakn Ls Europe Holdings Limited | 1,3-benzodioxole esters and their therapeutic use |
WO2023156565A1 (en) | 2022-02-16 | 2023-08-24 | Awakn Ls Europe Holdings Limited | Bridged ring compounds and their therapeutic use as cns agents |
WO2023235618A1 (en) | 2022-06-03 | 2023-12-07 | Biomea Fusion, Inc. | Fused pyrimidine compounds as inhibitors of menin |
WO2024011142A1 (en) | 2022-07-06 | 2024-01-11 | Oppilan Pharma Limited | Crystalline forms of an s1p receptor modulator |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
US3995631A (en) * | 1971-01-13 | 1976-12-07 | Alza Corporation | Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4180073A (en) * | 1977-08-29 | 1979-12-25 | Alza Corporation | Device for delivering drug to biological environment |
US4217898A (en) * | 1978-10-23 | 1980-08-19 | Alza Corporation | System with microporous reservoir having surface for diffusional delivery of agent |
US4235236A (en) * | 1979-02-12 | 1980-11-25 | Alza Corporation | Device for dispensing drug by combined diffusional and osmotic operations |
US4320759A (en) * | 1980-04-28 | 1982-03-23 | Alza Corporation | Dispenser with diffuser |
US4350271A (en) * | 1980-08-22 | 1982-09-21 | Alza Corporation | Water absorbing fluid dispenser |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4439196A (en) * | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
US4449983A (en) * | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
US4673405A (en) * | 1983-03-04 | 1987-06-16 | Alza Corporation | Osmotic system with instant drug availability |
US4765989A (en) * | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
NZ206600A (en) * | 1983-05-11 | 1987-01-23 | Alza Corp | Osmotic drug delivery device |
US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
GB8319766D0 (en) * | 1983-07-22 | 1983-08-24 | Graham N B | Controlled release device |
GB2150830B (en) * | 1983-12-05 | 1987-08-19 | Alza Corp | Drug dispenser |
US4663286A (en) * | 1984-02-13 | 1987-05-05 | Damon Biotech, Inc. | Encapsulation of materials |
US4595583A (en) * | 1984-03-19 | 1986-06-17 | Alza Corporation | Delivery system controlled administration of beneficial agent to ruminants |
US4684524A (en) * | 1984-03-19 | 1987-08-04 | Alza Corporation | Rate controlled dispenser for administering beneficial agent |
US4772474A (en) * | 1985-08-09 | 1988-09-20 | Alza Corporation | Dispenser with internal arrangement of lamina means for dispensing beneficial agent |
US4678467A (en) * | 1984-03-21 | 1987-07-07 | Alza Corporation | Dispenser comprising capsule with volume displacing member |
US4615698A (en) * | 1984-03-23 | 1986-10-07 | Alza Corporation | Total agent osmotic delivery system |
CA1266827A (en) * | 1984-06-20 | 1990-03-20 | Merck & Co., Inc. | Controlled porosity osmotic pump |
US4608048A (en) * | 1984-12-06 | 1986-08-26 | Alza Corporation | Dispensing device with drug delivery patterns |
US4685918A (en) * | 1985-02-01 | 1987-08-11 | Merck & Co., Inc. | Lipid osmotic pump |
CA1242394A (en) * | 1985-03-07 | 1988-09-27 | Neil B. Graham | Controlled release device |
US4627971A (en) * | 1985-04-22 | 1986-12-09 | Alza Corporation | Osmotic device with self-sealing passageway |
US4666704A (en) * | 1985-05-24 | 1987-05-19 | International Minerals & Chemical Corp. | Controlled release delivery system for macromolecules |
GB8521494D0 (en) * | 1985-08-29 | 1985-10-02 | Zyma Sa | Controlled release tablet |
US4723957A (en) * | 1986-02-07 | 1988-02-09 | Alza Corp. | System for delivering drug with enhanced bioacceptability |
US4842867A (en) * | 1986-05-09 | 1989-06-27 | Alza Corporation | Pulsed drug delivery of doxylamine |
US4716496A (en) * | 1986-05-09 | 1987-12-29 | Eaton Corporation | Panel-mounted control station housing |
US4816264A (en) * | 1986-06-06 | 1989-03-28 | Warner-Lambert Company | Sustained release formulations |
ES2022454B3 (es) * | 1986-06-17 | 1991-12-01 | Recordati Ind Chimica E Farm S P A | Sistema terapeutico para la liberacion controlada de drogas. |
GB8616669D0 (en) * | 1986-07-09 | 1986-08-13 | Merk Sharpe & Dohme Ltd | Pharmaceutical compositions |
CH668187A5 (de) * | 1986-08-07 | 1988-12-15 | Ciba Geigy Ag | Therapeutisches system mit systemischer wirkung. |
DE3629994A1 (de) * | 1986-09-03 | 1988-03-17 | Weissenbacher Ernst Rainer Pro | Vorrichtung zur medikamentenapplikation in koerperhoehlen bzw. auf koerperoberflaechen |
US4859470A (en) * | 1988-06-02 | 1989-08-22 | Alza Corporation | Dosage form for delivering diltiazem |
US4902514A (en) * | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
-
1990
- 1990-01-04 IL IL9296690A patent/IL92966A/en not_active IP Right Cessation
- 1990-01-10 EP EP90300301A patent/EP0378404B1/en not_active Expired - Lifetime
- 1990-01-10 MY MYPI90000046A patent/MY105761A/en unknown
- 1990-01-10 ES ES90300301T patent/ES2058775T3/es not_active Expired - Lifetime
- 1990-01-10 CA CA002007463A patent/CA2007463C/en not_active Expired - Fee Related
- 1990-01-10 AT AT90300301T patent/ATE110578T1/de not_active IP Right Cessation
- 1990-01-10 DK DK90300301.0T patent/DK0378404T3/da active
- 1990-01-10 DE DE69011878T patent/DE69011878T2/de not_active Expired - Fee Related
- 1990-01-11 JP JP2004419A patent/JPH07119171B2/ja not_active Expired - Fee Related
- 1990-01-11 NO NO90900151A patent/NO900151L/no unknown
- 1990-01-11 ZA ZA90197A patent/ZA90197B/xx unknown
- 1990-01-11 IE IE10490A patent/IE64201B1/en not_active IP Right Cessation
- 1990-01-11 AU AU47877/90A patent/AU615129B2/en not_active Ceased
- 1990-01-11 HU HU90108A patent/HUT54038A/hu unknown
- 1990-01-11 KR KR1019900000280A patent/KR920008702B1/ko not_active IP Right Cessation
- 1990-01-11 FI FI900153A patent/FI900153A/fi not_active Application Discontinuation
- 1990-01-11 PT PT92838A patent/PT92838B/pt not_active IP Right Cessation
- 1990-01-11 NZ NZ232078A patent/NZ232078A/xx unknown
-
1992
- 1992-10-09 US US07/960,186 patent/US5516527A/en not_active Expired - Fee Related
-
1996
- 1996-04-19 US US08/635,312 patent/US5792471A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IE64201B1 (en) | 1995-07-12 |
AU4787790A (en) | 1990-07-19 |
ATE110578T1 (de) | 1994-09-15 |
FI900153A (fi) | 1990-07-13 |
JPH07119171B2 (ja) | 1995-12-20 |
ZA90197B (en) | 1991-07-31 |
HUT54038A (en) | 1991-01-28 |
NO900151D0 (no) | 1990-01-11 |
IL92966A (en) | 1995-07-31 |
IE900104L (en) | 1990-07-12 |
CA2007463A1 (en) | 1990-07-12 |
US5516527A (en) | 1996-05-14 |
US5792471A (en) | 1998-08-11 |
ES2058775T3 (es) | 1994-11-01 |
DK0378404T3 (da) | 1994-10-03 |
DE69011878T2 (de) | 1994-12-15 |
KR920008702B1 (ko) | 1992-10-08 |
PT92838A (pt) | 1990-07-31 |
AU615129B2 (en) | 1991-09-19 |
EP0378404A3 (en) | 1990-10-03 |
CA2007463C (en) | 1995-01-17 |
EP0378404A2 (en) | 1990-07-18 |
FI900153A0 (fi) | 1990-01-11 |
DE69011878D1 (de) | 1994-10-06 |
HU900108D0 (en) | 1990-03-28 |
JPH02229110A (ja) | 1990-09-11 |
PT92838B (pt) | 1996-02-29 |
MY105761A (en) | 1995-01-30 |
NO900151L (no) | 1990-07-13 |
EP0378404B1 (en) | 1994-08-31 |
IL92966A0 (en) | 1990-09-17 |
NZ232078A (en) | 1991-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900011486A (ko) | 하이드로겔에 의해 작동되는 분배장치 | |
ES2075444T3 (es) | Sistema de dosificado osmotico para la administracion de un farmaco liquido. | |
KR880002502A (ko) | 산에 민감한 유익한 약제의 투여용 제형(劑形) | |
SE9102072D0 (sv) | Oral, fast, farmaceutisk doseringsform med styrd frisaettning | |
ATE269709T1 (de) | Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff | |
DK136186A (da) | Laegemiddelbaerer | |
NO891680D0 (no) | Osmotisk kontinuerlig avgivende oralt avgivelsessystem inneholdende et farmasoeytisk akseptabelt aktivt middel som har forbedrede kjernemembran-adhesjonsegenskaper. | |
DE60005819D1 (de) | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe | |
DK469989D0 (da) | Farmaceutisk praeparat | |
SE9402431D0 (sv) | New tablet formulation | |
ITMI922192A1 (it) | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' | |
ES2097787T3 (es) | Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon. | |
CA2398893A1 (en) | Improvements in and relating to controlling drug delivery apparatus | |
PT98802A (pt) | Processo para a preparacao dum dispositivo osmotico com a forma de dosagem unitaria para a administracao de farmacos com velocidade de libertacao programada | |
DE769938T1 (de) | Mehrschichtige Kapseln mit einer Siliconharzfüllung | |
ES2051881T3 (es) | Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada. | |
DE69940673D1 (de) | Orales system zur verabreichung von gepulsten dosen eines arzneistoffs | |
DE69309540T3 (de) | Orale Arzneimittel mit kolonspezifischer Freisetzung | |
IT8322832A0 (it) | Dispositivo per la somministrazione controllata di farmaci. | |
ATE63059T1 (de) | Vorrichtung mit zwei schichten zur freisetzung von arzneimitteln. | |
ES2016620B3 (es) | Sistema para liberar medicamentos con bioaceptabilidad mejorada. | |
AR036838A1 (es) | Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende. | |
ES2113985T3 (es) | Material de recubrimiento para formas medicamentosas de administracion oral. | |
ATE59551T1 (de) | Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung. | |
JO1881B1 (en) | Formula II for multi unit disc calibration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20021002 Year of fee payment: 11 |
|
LAPS | Lapse due to unpaid annual fee |